IDEAYA Intends To Offer And Sell Up To $125M Of Shares Of Its Common Stock And, In Lieu Of Common Stock, To Offer And Sell To Certain Investors Pre-funded Warrants
Portfolio Pulse from Benzinga Newsdesk
IDEAYA Biosciences, Inc. (IDYA) plans to offer and sell up to $125 million of its common stock. In lieu of common stock, the company will offer and sell pre-funded warrants to certain investors.
October 24, 2023 | 8:13 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
IDEAYA Biosciences is planning to raise up to $125 million through the sale of its common stock and pre-funded warrants. This could dilute existing shareholders' equity.
The sale of common stock or pre-funded warrants increases the number of shares in circulation, which can dilute the value of existing shares. This could potentially lead to a decrease in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100